COVID-19
Pharmafile.com’s weekly COVID-19 news round-up
July 22, 2020Research and Development COVID-19, coronavirus
The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …
India begins human trials of its first homegrown coronavirus vaccine
July 21, 2020Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus
India has begun human trials of its first internally developed vaccine for COVID-19. The Indian Council of Medical Research have …
AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data
July 21, 2020Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus
Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait
July 21, 2020Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus
Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …
North Korea says it’s developing its own coronavirus vaccine
July 21, 2020Manufacturing and Production COVID-19, North Korea, coronavirus
North Korea has announced it is developing a vaccine against COVID-19. The announcement was made on 18 July by the …
Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India
July 20, 2020Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir
Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …
Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show
July 20, 2020Research and Development, Sales and Marketing COVID-19, Synairgen
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
Israeli doctor tests positive for coronavirus 3 months after recovering
July 20, 2020Sales and Marketing COVID-19, coronavirus
An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …
UK secures early access to 90 million doses of coronavirus vaccines
July 20, 2020Sales and Marketing COVID-19, coronaviurs, vaccines
The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.
WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption
July 17, 2020Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines
The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …
Hydroxychloroquine proves ineffective against COVID-19 in newest trial
July 17, 2020Medical Communications COVID-19, coronavirus, hydroxychloroquine
The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients. A recent study was published in the …
Novartis to provide ‘no-profit’ generics to low income countries to help combat COVID-19
July 16, 2020Business Services COVID-19, Novartis, coronavirus, hydroxychloroquine
The Sandoz division of Novartis will not make a profit on the 15 generics it is making available to developing …
UK lockdown caused infection ‘R’ rate to drop as low as 0.57, according to a new study
July 15, 2020Research and Development COVID, COVID-19, Lockdown, coronavirus
A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted. …
Moderna’s COVID-19 vaccine candidate set for final testing in the US
July 15, 2020Research and Development COVID-19, coronavirus
The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing. The experimental …
Pharmafile.com’s weekly COVID-19 news round-up
July 15, 2020Research and Development COVID-19, coronavirus, vaccines
The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
